Learn about smoldering myeloma and the first treatment approved by the U.S. Food and Drug Administration to prevent its...
When we think about “cancer scientists,” we typically conjure images of physicians treating their patients or biologists analyzing cells...
Prostate cancer is one of the most common cancers diagnosed in the United States. About one-third of men diagnosed...
A little-talked-about provision of the 2010 Patient Protection and Affordable Care Act designed to improve access to innovative medical...
The relationship between cigarette smoking and lung cancer was first brought to the public’s attention more than 50 years...
The San Antonio Breast Cancer Symposium (SABCS), which marks its 40th anniversary this year, has become the world's premier...
The U.S. Food and Drug Administration (FDA) recently approved expanding the use of the antibody–drug conjugate brentuximab vedotin (Adcetris)...
Kent Osborne, MD, a codirector of SABCS, wrote a guest post for Cancer Research Catalyst in 2015 that details...
Next to skin cancer, prostate cancer is the most diagnosed cancer among men in the United States. Data from...
Recently, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic vemurafenib (Zelboraf) for treating certain adults...
Much has been written, including on this blog, about the rapidly expanding use of immunotherapy to treat an increasing...